Hikma Pharmaceuticals is a UK-headquartered global pharmaceutical company founded in 1978 in Jordan by Samih Darwazah. Specializing in generic, branded, and in-licensed medicines, Hikma operates 29 manufacturing plants across 10 countries, including the U.S. Portugal, Italy, Jordan, Saudi Arabia, Algeria, Germany, Egypt, Morocco, and Tunisia. The company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. In 2024, Hikma reported revenues of 3.16 billion and employed approximately 8,800 people.